
Learning Center
Development of an Evidence-Based List of Vesicant Medications and Solutions [virtual]
Extravasation may result in severe patient injuries including scarring, permanent functional impairment, and even loss of a limb. Such injuries are preventable when clinicians identify which medications and solutions are vesicants, understand infusion-related risks, and implement preventative interventions. Vesicant medications and solutions not used in cancer treatment are commonly administered by nonspecialty nurses, often via peripheral intravenous (IV) catheters. There are critical issues and risks especially related to peripheral vesicant administration, increasingly via midline catheters. An INS task force was formed to review and update the 2017 vesicant list, identify current issues and risks relative to vesicant administration, and revise the extravasation prevention checklist. In this session, the task force, in a panel presentation, will present the updated 2023 vesicant list and discuss critical issues in extravasation prevention.
Learning Objectives: At the conclusion of this session, participants will be able to:
- Identify vesicant medications and solutions.
- Examine issues associated with peripheral vesicant administration.
- Analyze extravasation prevention strategies.
- Apply extravasation prevention strategies in their health care organization.
Contact Hours: 1
CRNI® RUs: 2

Lynn Hadaway, M.Ed., RN, NPD-BC, CRNI®
Lynn Hadaway has 50 years of experience in infusion nursing. Her clinical experience comes from infusion therapy teams in multiple acute care settings. She is president of Lynn Hadaway Associates, Inc., an education and consulting company started in 1996. She holds two national certifications—infusion nursing from the Infusion Nurses Certification Corporation and nursing professional development from the American Nurses Credentialing Corporations—as well as a master’s in education from the University of Georgia. She has authored more than 75 published articles and 8 textbook chapters on infusion therapy and vascular access and was the clinical editor for Infusion Therapy Made Incredibly Easy. She served on the Infusion Nurses Society Standards of Practice committees to revise the 2006, 2011, 2016, and 2021 Standards of Practice, and served on the committees to revise the 2014 and 2022 Society for Healthcare Epidemiology of America Compendium (SHEA) CLABSI chapter and the 2015 Association for Professionals in Infection Control and Epidemiology (APIC) CLABSI Implementation Guide.

Barb Nickel, APRN-CNS, CCRN, CRNI®
Barb Nickel, APRN-CNS, CCRN, CRNI®, is a Clinical Nurse Specialist at a health care center in Nebraska. She is responsible for staff development, competency assessment, and process improvement to optimize outcomes in multiple areas of clinical practice, including critical care, infusion therapy, sepsis, and new graduate transition to practice. Ms Nickel was a co-author of the 2021 Infusion Nurses Society Infusion Therapy Standards of Practice, was Chair of the 2024 9th edition of the INS Standards of Practice Committee and is chair of the 2027 INS Standards Committee. She has authored several publications and speaks nationally on optimization of infusion therapy outcomes. She also serves as Adjunct Research Fellow for Griffith University, Queensland, Australia.

Lisa Gorski, MS, RN, HHCNS-BC, CRNI®, FAAN
Lisa Gorski, MS, RN, HHCNS-BC, CRNI®, FAAN, has worked for more than 35 years as a clinical nurse specialist (CNS) and educator for Wheaton Franciscan Home Health and Hospice, which is now Ascension at Home. As a CNS, she developed a home infusion therapy program in collaboration with the pharmacy and continues to provide infusion-related education for home care nurses as well as direct patient care. Ms Gorski received both her bachelor’s and master’s degrees from the University of Wisconsin-Milwaukee College of Nursing. She is the author of several books and more than 7 book chapters and journal articles. She is an INS past president (2007-2008), past Chair of the Infusion Nurses Certification Corporation (INCC) Board of Directors and has served as the chair of the INS Standards of Practice Committee for the 2011, 2016, and 2021 editions and Co-Chair for the 2024 Standards. Ms Gorski was also the Chair for the 2017 and 2024 INS Vesicant Task Force. She was inducted as a fellow into the American Academy of Nursing in 2006, named the CRNI® of the year by INCC, and named 2011 CNS of the Year by the National Association of Clinical Nurse Specialists. Ms Gorski speaks nationally and internationally on standards development, infusion therapy/vascular access, and home health care. Over the years, she has addressed the Standards in multiple presentations in the US, China, Europe, and Middle Eastern African and Latin American countries.
Key:




